Evagene unifies pedigree drawing, clinical data modelling, and Bayesian risk analysis in a single platform. Standard ISCN/HGNC notation. Integrated BayesMendel engine (BRCAPRO, MMRpro, PancPRO). A 184-disease catalog with ICD-10 and OMIM codes. Zero installs.
Paper charts get lost in handover. General-purpose diagramming tools don't understand affection fill or proband arrows. Legacy genetics software forces you to re-key family data into a separate BayesMendel calculator — and none of it runs in a browser.
The result: consultation time wasted on tools rather than patients. Incompatible exports between research teams. Families locked out of their own history.
Evagene combines gesture-based pedigree drawing, deep clinical data modelling, Bayesian risk analysis, and universal data exchange — in a single browser application with no installation.
Draw a circle for a female. A square for a male. Connect them. Add diseases with ICD-10 codes. Run BRCAPRO. Export to PDF. That is the entire workflow.
From gesture-based canvas drawing to Bayesian cancer risk models and GEDCOM interoperability — clinical-grade power in an interface anyone can learn in minutes.
Freehand-draw circles, squares, and diamonds on the HTML5 canvas. Draw lines to form relationships. Natural as pen and paper, with keyboard accelerators.
Internationally recognised pedigree symbols: affection fill, carrier dots, half-fill, mortality overlays, consanguinity double-lines, proband arrows, and fertility indicators.
Floating draggable panel: identity (8 biological sex options), death status (12 options), lifestyle, contact fields, consent-to-share flags, relationship events — all synced in real time.
Oncology, cardiology, neurology, metabolic — each entry carries ICD-10, OMIM, inheritance pattern, penetrance tables, and carrier frequencies by ethnicity.
BRCAPRO, MMRpro, PancPRO via the peer-reviewed BayesMendel engine. Plus autosomal dominant/recessive and X-linked Mendelian models with age-dependent penetrance.
Ideogram of all chromosomes with genetic markers at genomic positions, colour-coded by test result (positive / VUS / negative), with centromere bands.
Import JSON, GEDCOM 5.5.1, XEG, 23andMe, and images (OCR). Export to JSON, GEDCOM, PNG (up to 4x), SVG, and PDF (A4/A3/Letter/Legal).
Wright's path coefficient calculates consanguinity coefficients automatically. Values display on relationship lines and feed directly into risk models.
Query builder: filter by sex, disease status, age, tests, treatments — across parents, siblings, ancestors, descendants. AND/OR modes. Results highlighted on canvas.
Screen a proband across multiple diseases simultaneously. Generate dual-audience reports: one written for the patient, one for the clinical geneticist.
59 allergies (severity, IgE, cross-reactivity). 51 traits (heritability, marker associations). Enables genotype-phenotype correlation in a unified model.
Algorithm-based positioning respecting family structure. Undo/redo, copy/paste, lasso select, snap-to-grid, pinch zoom, light/dark theme, configurable fonts.
Ready to draw your first pedigree?
Request Alpha AccessFrom specialist geneticists to patients documenting family history — Evagene adapts to your workflow and expertise level.
Every symbol, fill pattern, and overlay follows standard clinical pedigree conventions — eliminating the ambiguity of hand-drawn charts and the limitations of diagramming tools.
The BayesMendel R engine runs as a sidecar process. Select a proband, choose a model, click Run Analysis. Carrier probabilities and age-specific risk tables appear in the same panel — no copy-paste, no data re-entry.
BRCA1/BRCA2 carrier probability. Cumulative breast and ovarian cancer risk at ages 40, 50, 60, 70, 80.
MLH1/MSH2/MSH6 carrier probability. Colorectal and endometrial cancer risk by age. ~3% of all CRC.
Pancreatic cancer susceptibility. FPC families face 5–30× general-population risk.
Select a family scenario below to see how carrier probabilities and risk change with family history.
Built-in models for autosomal dominant, autosomal recessive, and X-linked recessive. Advanced parameters:
Import from clinical systems, genealogy platforms, and consumer genomics. Export publication-ready output in any format.
| Format | Import | Export | Notes |
|---|---|---|---|
| JSON | ✓ | ✓ | Full snapshot; replace or add mode |
| GEDCOM 5.5.1 | ✓ | ✓ | Ancestry, FamilySearch, Gramps compatible |
| XEG | ✓ | — | Legacy Evagene v1 XML migration |
| 23andMe | ✓ | — | Genotype, ancestry, DNA relatives, phenotype |
| Image | ✓ | — | OCR + shape detection from chart photos |
| PNG | — | ✓ | 1x–4x scale, optional transparency |
| SVG | — | ✓ | Vector for publication-quality output |
| — | ✓ | A4/A3/Letter/Legal, portrait/landscape/auto |
Every disease name, genetic marker, and risk result in Evagene links directly to its guide. The help system doubles as a comprehensive genetics education resource.
Covers the central dogma (DNA → RNA → protein), chromosome structure, Mendelian inheritance patterns, and how mutations lead to disease. Written for readers with no prior genetics background. Includes diagrams of DNA replication, meiosis, and autosomal vs. X-linked inheritance.
BRCAPRO uses Bayesian updating with the BayesMendel R package to estimate BRCA1/BRCA2 carrier probability from family pedigree data. Supports General, Ashkenazi Jewish, and Italian population frequencies. Carrier probability ≥10% is considered clinically actionable; ≥25% is strongly suggestive of hereditary breast and ovarian cancer syndrome.
ICD-10: C50. OMIM: 114480. Inheritance: multifactorial with high-penetrance genes (BRCA1, BRCA2, TP53, PALB2). Lifetime risk ~12% general population; up to 72% for BRCA1 carriers. Evagene tracks laterality, ER/PR/HER2 status, grade, stage, and age at diagnosis per individual.
M/F/U to add individuals, P for partner, D for disease palette, N for notes, G for genetics panel. Ctrl+Z/Y for undo/redo, Ctrl+C/V for copy/paste, Ctrl+A to select all, F2 to edit name, Delete to remove. Space+drag to pan, scroll to zoom, Ctrl+G for snap-to-grid.
Be among the first to use Evagene. Alpha members receive early access, direct input on the roadmap, and priority support from the development team.
We'll notify you as soon as alpha access opens. In the meantime, share Evagene with colleagues who work with pedigrees.
Join clinicians, researchers, and families already on the waiting list. Early members shape the roadmap and receive priority support.
Request Alpha Access